Relypsa Inc (RLYP) was among the biggest gainers on the Russell 2000 for Thursday February 11 as the stock popped 8.61% to $17.15, representing a gain of $1.3589 per share. Some 2.24 million shares traded hands on 10,771 trades, compared with an average daily volume of 2.51 million shares out of a total float of 41.69 million. The stock opened at $15.50 and traded with an intraday range of $17.34 to $14.80.
After today's gains, Relypsa Inc reached a market cap of $714.96 million. Relypsa Inc has had a trading range between $42.26 and $10.26 over the last year, and it had a 50-day SMA of $23.24 and a 200-day SMA of $26.01.
Relypsa Inc is a biopharmaceutical company engaged in the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.
Relypsa Inc is based out of Redwood City, CA and has some 241 employees. Its CEO is John A. Orwin.
For a complete fundamental analysis analysis of Relypsa Inc, check out Equities.com’s Stock Valuation Analysis report for RLYP. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.